1. Home
  2. BCDA vs WHLR Comparison

BCDA vs WHLR Comparison

Compare BCDA & WHLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • WHLR
  • Stock Information
  • Founded
  • BCDA N/A
  • WHLR 2011
  • Country
  • BCDA United States
  • WHLR United States
  • Employees
  • BCDA N/A
  • WHLR N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • WHLR Real Estate Investment Trusts
  • Sector
  • BCDA Health Care
  • WHLR Real Estate
  • Exchange
  • BCDA Nasdaq
  • WHLR Nasdaq
  • Market Cap
  • BCDA 7.9M
  • WHLR 3.7M
  • IPO Year
  • BCDA N/A
  • WHLR 2012
  • Fundamental
  • Price
  • BCDA $2.45
  • WHLR $5.07
  • Analyst Decision
  • BCDA Strong Buy
  • WHLR
  • Analyst Count
  • BCDA 1
  • WHLR 0
  • Target Price
  • BCDA $25.00
  • WHLR N/A
  • AVG Volume (30 Days)
  • BCDA 54.7K
  • WHLR 1.2M
  • Earning Date
  • BCDA 03-26-2025
  • WHLR 03-04-2025
  • Dividend Yield
  • BCDA N/A
  • WHLR N/A
  • EPS Growth
  • BCDA N/A
  • WHLR N/A
  • EPS
  • BCDA N/A
  • WHLR N/A
  • Revenue
  • BCDA $71,000.00
  • WHLR $102,749,000.00
  • Revenue This Year
  • BCDA N/A
  • WHLR N/A
  • Revenue Next Year
  • BCDA N/A
  • WHLR N/A
  • P/E Ratio
  • BCDA N/A
  • WHLR N/A
  • Revenue Growth
  • BCDA N/A
  • WHLR N/A
  • 52 Week Low
  • BCDA $1.63
  • WHLR $4.79
  • 52 Week High
  • BCDA $8.85
  • WHLR $3,801.60
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 56.72
  • WHLR 23.77
  • Support Level
  • BCDA $2.12
  • WHLR $5.60
  • Resistance Level
  • BCDA $2.73
  • WHLR $7.44
  • Average True Range (ATR)
  • BCDA 0.22
  • WHLR 1.01
  • MACD
  • BCDA 0.03
  • WHLR 0.47
  • Stochastic Oscillator
  • BCDA 58.21
  • WHLR 4.26

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About WHLR Wheeler Real Estate Investment Trust Inc.

Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.

Share on Social Networks: